Prevalence and Predictors of Complementary Therapy Use in Advanced-Stage Breast Cancer Patients

Abstract

Use of unconventional therapies is pervasive among metastatic breast cancer patients, particularly among those who are younger and highly educated. Oncology providers need to assess patients' complementary therapy use and consider potential interactions with prescribed treatment protocols.